Inactive Instrument
Urovant Sciences Ltd. Stock
Stocks
UROV
BMG9381B1081
Biotechnology & Medical Research
| 1 day | +0.06% |
| Manager | Title | Age | Since |
|---|---|---|---|
James Robinson
CEO | Chief Executive Officer | 56 | 23/03/2020 |
Ajay Bansal
DFI | Director of Finance/CFO | 64 | 28/10/2019 |
| Chief Tech/Sci/R&D Officer | 68 | 01/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Sef P. Kurstjens
BRD | Director/Board Member | 62 | 01/07/2018 |
James Robinson
BRD | Director/Board Member | 56 | 01/03/2019 |
| Director/Board Member | 61 | 27/12/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/29/21 A | Issuer sale | Director | 111,480 | 0.3405% | ||
| 3/29/21 A | Issuer sale | Director | 111,480 | 0.3405% | ||
| 3/29/21 A | Issuer sale | Controller/Auditor | 286,031 | 0.8736% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | +0.06% | - | - | 373M | |
| +3.80% | +8.10% | +63.78% | +77.70% | 69.4B | |
| -2.89% | -1.88% | +7.40% | +71.50% | 57.24B | |
| -2.17% | +2.79% | +24.57% | +99.82% | 57.62B | |
| +0.41% | -3.70% | +26.06% | +34.32% | 43.65B | |
| +2.51% | +4.22% | +20.49% | +110.71% | 44.03B | |
| -11.04% | -6.63% | +199.38% | +701.67% | 38.08B | |
| +7.50% | +13.58% | +29.07% | +64.46% | 36.31B | |
| -4.35% | -10.89% | +86.67% | +74.13% | 32.61B | |
| -2.18% | +7.06% | +36.06% | -4.95% | 25.47B | |
| Average | -0.82% | +2.80% | +54.83% | +136.60% | 44.93B | |
| Weighted average by Cap. | -0.59% | +3.12% | +51.18% | +130.95% |
Employees
-
